Latest filing published 20 Oct 2010 for VALEANT PHARMACEUTICALS INTERNATIONAL.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Elisa A. Karlson discloses dealings in Valeant Pharmaceuticals International to SEC (Form 4). Between 20 May 2008 and 28 September 2010, the trades on record add up to 21 filings.
The open-market record is one-sided, with 7 purchases worth €205k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 13 share grants.
A typical purchase (the median) is worth €22k.
The newest entry dates from 20 October 2010: a transaction, in Valeant Pharmaceuticals International. The clock since the last published purchase (12 March 2009) now reads 6,434 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations